NCT lookup
Pull any trial record directly from ClinicalTrials.gov.
Sponsor: McMaster University
Conditions: Long COVID
Interventions: Lightning Process, Activity Pacing
Long COVID affects about 6 in 100 people after a COVID-19 infection. It can cause ongoing problems like ongoing tiredness, muscle pain, and "brain fog." We know very little about which treatments might be helpful for long COVID. The goal of this trial is to compare two treatments for people with long COVID to try to manage their symptoms. The main question is to assess whether the Lightning Process is effective for people living with long COVID compared to activity pacing. Each person will be placed into one of the two groups randomly (by chance, like flipping a coin). Activity pacing helps people balance rest and daily activities. The Lightning Process teaches ways to change thought patterns and body responses to symptoms. We will include 100 adults with long COVID. Everything will be done online, including filling out surveys about health and daily life. The goal is to find out which approach helps people feel better and improve their daily activities.
Sex: ALL
Age: 18 Years to 65 Years
Healthy volunteers: No
Study type: INTERVENTIONAL
Inclusion Criteria: * The inclusion criteria for participants are: 1. Adults aged 18 to 65 years 2. Meeting the WHO clinical case definition for long COVID and 3. Self-reported experiencing long COVID symptoms such as fatigue, muscle pain, and brain fog. 4. Reporting a minimum score of ≥35 on the Checklist Individual Strength CIS-fatigue domain. 5. Able to speak and read English 6. Scoring higher in contemplation, action or maintenance scores than the precontemplation phase on the readiness to change questionnaire 7. Provides consent for study participation. 8. Consistent access to an internet-connected device (e.g., smartphone, tablet, laptop) that can facilitate access to the study interventions. Exclusion Criteria: * The exclusion criteria are: 1. Long COVID participants whose presentation is primarily restricted to anosmia. 2. Participants with Post-Intensive Care Syndrome (PICS) or serious organic sequelae of COVID-19, such as structural lung injury attributable to mechanical ventilation or other organ damage requiring ongoing specialist management. 3. Participants who will not be able to attend intervention sessions or follow up visits due to anticipated significant life changes or relocation. 4. Unable to provide informed consent (e.g. cognitive disability, language barrier) 5. Co-morbidities that likely to impair function for as long or longer than long COVID 6. Current participation in psychotherapy, structured physical rehabilitation (e.g., physiotherapy or occupational therapy), or another trial that does not permit co-enrollment.